Evidence map›Paper›PMID 31524836›Full record

ArticleThe journal of trauma and acute care surgery2020

Prehospital plasma in injured patients is associated with survival principally in blunt injury: Results from two randomized prehospital plasma trials.

Katherine M Reitz, Hunter B Moore, Frank X Guyette, Angela Sauaia, Anthony E Pusateri, Ernest E Moore, Adnan Hassoune, Michael P Chapman, Brian J Daley, Richard S Miller and 8 more

Abstract read
In one paragraph

Article in The journal of trauma and acute care surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Prehospital plasma transfusion versus standard of care following traumatic injury: a review of the systematic reviews and a meta-analysis.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Is Mechanism a Biological Variable?: A Secondary Analysis of the PROPPR Trial.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Katherine M ReitzFrom the Department of Surgery (K.M.R., A.H., J.B.B., B.S.Z., M.D.N., J.L.S.), University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Surgery (H.B.M., A.S., E.E.M., M.P.C.), University of Colorado and Denver Health Medical Center, Denver, Colorado; Department of Emergency Medicine (F.X.G.), University of Pittsburgh, Pittsburgh, Pennsylvania; US Army Institute of Surgical Research (A.E.P.), JBSA Fort Sam Houston, San Antonio, Texas; Department of Surgery (B.J.D.), University of Tennessee Health Science Center, Knoxville; Department of Surgery (R.S.M.), Vanderbilt University Medical Center, Nashville, Tennessee; University of Louisville (B.G.H.), Louisville, Kentucky; MetroHealth Medical Center (J.A.C.), Case Western Reserve University, Cleveland, Ohio; Department of Surgery (H.A.P.), University of Texas Southwestern, Parkland Memorial Hospital, Dallas, Texas; Department of Pathology (M.H.Y.), University of Pittsburgh and Institute for Transfusion Medicine, Pittsburgh, Pennsylvania.
Hunter B Moore
Frank X Guyette
Angela Sauaia
Anthony E Pusateri
Ernest E Moore
Adnan Hassoune
Michael P Chapman
Brian J Daley
Richard S Miller
Brian G Harbrecht
Jeffrey A Claridge
Herb A Phelan
Joshua B Brown
Brian S Zuckerbraun
Matthew D Neal
Mark H Yazer
Jason L Sperry

Funding

Vascular Surgery Research Training (VascTrain) ProgramT32HL098036 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Edith Tzeng · 2010 to 2026
$7.2M
Mechanistic Elucidation and Targeted Therapy of Platelet Dysfunction After TraumaR35GM119526 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NEAL, MATTHEW D · 2016 to 2025
$3.9M
Pragmatic, Prehospital Group O Whole Blood Early Resuscitation Pilot TrialR34HL135224 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SPERRY, JASON LEE, TRIULZI, DARRELL J · 2017 to 2019
$594k
NHLBI NIH HHS R34 HL135224NHLBI NIH HHS T32 HL098036NIA NIH HHS L30 AG064730NIGMS NIH HHS R35 GM119526
6 · The paper itself

Abstract

introductionRecent evidence demonstrated that prehospital plasma in patients at risk of hemorrhagic shock was safe for ground transport and resulted in a 28-day survival benefit for air medical transport patients. Whether any beneficial effect of prehospital plasma varies across injury mechanism remains unknown.

methodsWe performed a secondary analysis using a harmonized data set derived from two recent prehospital plasma randomized trials. Identical inclusion/exclusion criteria and primary/secondary outcomes were used for the trials. Prehospital time, arrival shock parameters, and 24-hour transfusion requirements were compared across plasma and control groups stratified by mechanism of injury. Stratified survival analysis and Cox hazard regression were performed to determine the independent survival benefits of plasma across blunt and penetrating injury.

resultsBlunt patients had higher injury severity, were older, and had a lower Glasgow Coma Scale. Arrival indices of shock and coagulation parameters were similar across blunt and penetrating injury. The percentage of patients with a prehospital time less than 20 minutes was significantly higher for penetrating patients relative to blunt injured patients (28.0% vs. 11.6%, p < 0.01). Stratified Kaplan-Meier curves demonstrated a significant separation for blunt injured patients (n = 465, p = 0.01) with no separation demonstrated for penetrating injured patients (n = 161, p = 0.60) Stratified Cox hazard regression verified, after controlling for all important confounders, that prehospital plasma was associated with a 32% lower independent hazard for 28-day mortality in blunt injured patients (hazard ratio, 0.68; 95% confidence interval, 0.47-0.96; p = 0.03) with no independent survival benefit found in penetrating patients (hazard ratio, 1.16; 95% confidence interval, 0.4-3.1; p = 0.78).

conclusionA survival benefit associated with prehospital plasma at 24 hours and 28 days exists primarily in blunt injured patients with no benefit shown in penetrating trauma patients. No detrimental effects attributable to plasma are demonstrated in penetrating injury. These results have important relevance to military and civilian trauma systems. LEVEL OF EVIDENCE: Therapeutic, I.

Indexed as

PlasmaAdultAge FactorsBlood Component TransfusionCohort StudiesCrystalloid SolutionsDatasets as TopicFemaleFirst AidGlasgow Coma ScaleHumansInjury Severity ScoreMaleMiddle AgedRandomized Controlled Trials as TopicResuscitationCrystalloid Solutions

Identifiers

PMID31524836
PMCPMC6923541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.